Encyclopedia of Autism Spectrum Disorders

Living Edition
| Editors: Fred R. Volkmar

Zolpidem

  • Jonathan Kopel
Living reference work entry
DOI: https://doi.org/10.1007/978-1-4614-6435-8_102296-1

Synonyms

Definition

Despite its high prevalence, few pharmacological treatments outside antihistamines and melatonin exist for sleep disorders among pediatric populations (Chevreuil et al. 2010). Few clinical trials have examined whether benzodiazepines, such as Zolpidem, may benefit autistic spectrum disorder (ASD) children with sleep disorders (Chevreuil et al. 2010). A recent case report suggests Zolpidem was effective in reducing catatonic behavior in an adolescent with ASD (Zaw and Bates 1997). However, murine models suggest zolpidem exacerbates social and cognitive deficits observed in ASD children (Banerjee et al. 2012; Han et al. 2014). Further clinical trials are required to elucidate the mechanism, therapeutic use, and side effects of Zolpidem among ASD children with sleep disorders.

See Also

References and Reading

  1. Banerjee, A., García-Oscos, F., Roychowdhury, S., Galindo, L. C., Hall, S., Kilgard, M. P., & Atzori, M. (2012). Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism. The International Journal of Neuropsychopharmacology, 16(06), 1309–1318.  https://doi.org/10.1017/s1461145712001216.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Chevreuil, C., Polard, E., Gicquel, G., Frémaux, T., & Bentué-Ferrer, D. (2010). Pharmacologic treatment of insomnia in children and adolescent psychiatric patients. Thérapie, 65(1), 1–12.  https://doi.org/10.2515/therapie/2010001.CrossRefPubMedGoogle Scholar
  3. Han, S., Tai, C., Jones, C. J., Scheuer, T., & Catterall, W. A. (2014). Enhancement of inhibitory neurotransmission by GABA A receptors having α 2,3 -subunits Ameliorates behavioral deficits in a mouse model of autism. Neuron, 81(6), 1282–1289.  https://doi.org/10.1016/j.neuron.2014.01.016.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Zaw, Z. F., & Bates, G. D. L. (1997). Replication of zolpidem test for catatonia in an adolescent. The Lancet, 349(9069), 1914.  https://doi.org/10.1016/s0140-6736(05)63915-3.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Texas Tech University Health Sciences Center (TTUHSC)LubbockUSA